Drugs / [131I]-SGMIB Anti-HER2 VHH1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02683083 | Oct 2016 → Feb 2018 | breast cancer | Precirix | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [131I]-SGMIB Anti-HER2 VHH1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02683083 ↗ |